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Abstract
Whole-body warm-up exercises were shown to attenuate exercise-induced bronchocon-
striction (EIB). Whether intense pre-exercise hyperpnea offers similar protection and
whether this might negatively affect exercise performance is unknown. Nine subjects with
EIB (25±5 yrs; forced expiratory volume in 1s [FEV1], 104±15% predicted) performed an
exercise challenge (ECh) followed—after 30min—by a constant-load cycling test to exhaus-
tion. The ECh was preceded by one of four conditions: by i) control warm-up (CON) or by
10min of normocapnic hyperpnea with partial rebreathing at either ii) 50% (WU50) or iii) vari-
able intensity (8x 30s-80%/45s-30%; WU80/30), or at iv) 70% (WU70) of maximal voluntary
ventilation. FEV1 was measured at baseline and in 5-min intervals until 15min after CON/
warm-up and 30min after ECh. None of the warm-up conditions induced EIB. The maximal
post-ECh decrease in FEV1 was -13.8±3.1% after CON, −9.3±5.0% after WU50 (p = 0.081
vs. CON), −8.6±7.5% after WU80/30 (p = 0.081 vs. CON) and −7.2±5.0% after WU70 (p =
0.006 vs. CON), and perception of respiratory exertion was significantly attenuated (all
p0.048), with no difference between warm-up conditions. Only after CON, FEV1 remained
significantly reduced up to the start of the cycling endurance test (−8.0±4.3%, p = 0.004).
Cycling performance did not differ significantly between test days (CON: 13±7min; WU50:
14±9min; WU80/30: 13±9min; WU70: 14±7min; p = 0.582). These data indicate that intense
hyperpnea warm-up is effective in attenuating EIB severity and accelerating lung function
recovery while none of the warm-up condition do compromise cycling performance.
Introduction
Regular physical exercise is increasingly recognized to improve not only cardio-pulmonary
functioning but also asthma-specific pathophysiological changes like airway inflammation and
hyperresponsiveness in asthmatics [1,2]. Nonetheless, most asthmatics show transient airway
obstruction during and after strenuous exercise [3], commonly termed exercise-induced
bronchoconstriction (EIB). Interestingly, improved EIB was observed in asthmatics in a
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second of two EIB-inducing exercise trials that were4 hours apart [4,5]. This so-called
refractory effect, i.e. a period of activity reducing the extent of EIB during a subsequent period
of activity, was also observed when the EIB-inducing exercise was preceded by exercise with a
different protocol (usually termed “warm-up”) in most [6–11] but not all studies [12], as
recently summarized by Stickland et al. [13] in a systematic review. Similarly, decreased EIB
after exercise was shown when 6min of intense hyperpnea (~78% maximal voluntary ventila-
tion, MVV) were performed 30-50min before the physical exercise challenge [14]. The refrac-
tory effect induced by non-pharmacological means is of particular interest for athletes since
preventive regular intake of anti-EIB medications (β2-agonists) could lead to EIB-worsening
[15,16] and thus possibly limit effective participation in exercise in the long run.
However, whole-body warm-up as well as hyperpnea warm-up exercises bear the risk of
inducing EIB by itself [6,7,9,11,14] which might compromise preparation for the subsequent
competition. Interestingly, one study showed that exercising with warm and humid air did not
induce substantial EIB but this exercise was still effective in preventing EIB in the following
exercise challenge [17]. From a practical point of view, however, warm-up exercise using
warm and humid air is a technically challenging approach. An alternative approach might be
volitional, isolated hyperpnea with partial rebreathing, keeping the inspirate warm and humid.
However, it remains unknown whether hyperpnea with warm and humid air, likely not induc-
ing bronchoconstriction [18], would be equally effective in reducing EIB as was shown for
hyperpnea with dry air that was used previously [14], inducing bronchoconstriction by itself.
Furthermore, it is unclear which hyperpnea protocol would provide the best protection since
different exercise warm-up protocols were shown to reduce EIB to different degrees [13]. For
whole-body exercise warm-up, Stickland et al. [13] concluded in their systematic review that at
least some high intensity exercise is needed to reduce EIB in a following exercise. Because ven-
tilation is frequently not reported in warm-up exercise trials and because systemic effects of
muscle activity are different between whole-body exercise and volitional breathing, it is diffi-
cult to determine the optimal intensity of volitional breathing required for similar warm-up
effects. In this context, also a potential side-effect needs consideration, i.e. hyperpnea intensi-
ties70% MVV were shown to induce respiratory muscle fatigue lasting up to 60min into
recovery [19]. This might, in fact, be disadvantageous for subsequent exercise performance
where respiratory muscle fatigue may further develop and compromise performance [20].
Therefore, the aim of the present study was to assess the effect of different pre-exercise
hyperpnea intensities, i.e. moderate- and high-intensity continuous hyperpnea as well as inter-
val-type hyperpnea with warm and humid air, on 1) inducing bronchoconstriction after
hyperpnea, 2) attenuating EIB after a subsequent exercise challenge and 3) affecting exercise
performance.
Method
Subjects
Nine subjects (6 females [one competitive swimmer, 14-16h/wk], 3 males; Table 1) with a his-
tory of EIB and a10% decline in forced expiratory volume in 1s (FEV1) in a control exercise
challenge (ECh) took part in this study. All subjects were non-smokers, were not taking any
medication (apart from asthma medication, Table 1) and did not have any acute or chronic
disease other than mild asthma (defined as controlled asthma with at most low-dose inhaled
corticosteroids, i.e. budesonide400μg d-1, [21]) and/or EIB or injuries that might affect per-
formance. Participants gave their written informed consent to take part in this study. The
study was approved by the ethics committee of the ETH Zurich and was performed according
to the Declaration of Helsinki (2008 Revision).
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Study design
Subjects reported to the laboratory on six different days with at least 48h between each session.
All test sessions were scheduled at the same time of day. Inhalation of long-acting and short-
acting β2-agonists was discontinued for 48h and 8h, respectively, prior to each testing session
(except for tests on the 1st day) while subjects continued taking their maintenance medica-
tions, if appropriate, in analogy to a previous study [10]. Subjects completely refrained from
physical exercise for 24h and from intake of caffeinated products on test days prior to testing.
In the 1st visit, airway impedance, lung function and MVV were measured and subjects
were familiarized with all procedures. In the following five visits (Fig 1), subjects performed
either no warm-up (10min of rest = CON, always 2nd visit), or one of four different 10-min
hyperpnea warm-up exercises (including one sham warm-up) in a randomized and balanced
order (3rd to 6th visit). Each of these 10-min pre-exercise interventions (2nd to 6th visit) was fol-
lowed—after a 15-min break—by an 8-min ECh and—after a 30-min break—by a constant-
load test (CET) to exhaustion. Prior to CON/warm-up and during the breaks, airway
Table 1. Characteristics of study participants.
Age (years) 24.8 ±4.5
Height (m) 1.71±0.10
Weight (kg) 69.3±8.7
BMI (kgm−2) 23.7±1.5
On controller medication (n = 4):
Inhaled corticosteroids (μgd−1) § 350±191
Long-acting β2-agonists (μgd−1) § 11±9
On reliever medication only (n = 3)
No medication (n = 2)
FVC (L) 5.03±0.84
FVC (% pred) 112±18
FEV1 (L) 3.99±0.75
FEV1 (% pred) 104±15
FEV1/FVC (%) 79.3±7.4
FEV1/FVC (% pred) 93±9
PEF (Ls−1) 8.35±1.50
PEF (% pred) 102±16
FEF25-75% (Ls−1) 3.68±1.21
FEF25-75% (% pred) 81±23
MVV (Lmin−1) 143.2±28.0
MVV (% pred) 103±10
R5 (kPaL−1s−1) 0.30±0.06
R20 (kPaL−1s−1) 0.31±0.07
R5-R20 (kPaL−1s−1) −0.01±0.01
X5 (kPaL−1s−1) −0.10±0.02
AX (kPaL−1) 0.20±0.08
Data are presented as mean ± SD (n = 9). BMI, body mass index; FVC, forced vital capacity; FEV1, forced
expiratory volume in 1s; PEF, peak expiratory flow; FEF25-75%, forced expiratory flow between 25 and 75%
FVC; MVV, maximal voluntary ventilation; R5, airway resistance at 5Hz; R20, airway resistance at 20Hz;
R5-R20, difference in airway resistance measured at 5 and 20Hz; X5, airway reactance at 5Hz, AX, airway
reactance area from 5Hz to resonance frequency; pred, predicted.
§ used in combination, all budesonide400μg d-1.
doi:10.1371/journal.pone.0167318.t001
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impedance, perception of respiratory sensations, and lung function were measured at 0, 5, 10
and 15min after CON/warm-up and at 2.5, 7.5, 12.5, 17.5, 22.5 and 27.5min after the ECh.
Hyperpnea warm-up
Pre-exercise hyperpnea warm-up consisted of normocapnic hyperpnea performed for 10min
with a device using partial rebreathing of expired air (SpiroTiger1, idiag, Fehraltorf, Switzer-
land) at a constant minute ventilation ( _VE) corresponding to 10% (SHAM), 50% (WU50), or
70% MVV (WU70) or at alternating intensities of 80% and 30% MVV (8 x 30s at 80% inter-
spaced by 45s at 30% MVV, [WU80/30]) with given respiratory frequency (fR) and tidal vol-
ume (VT; set at 50–60% forced vital capacity, FVC), reinforced by an experimenter, if
necessary. End-tidal CO2 partial pressure (PETCO2) was monitored using a metabolic cart
(OxyconPro, Jaeger, Ho¨chberg, Germany) to assure it stayed in the normocapnic range. In the
CON condition, subjects rested in a chair for 10min.
Exercise challenge and endurance test
The ECh consisted of cycling for 8min on a bicycle ergometer (Ergoline 800s / Ergoselect 200k,
Ergoline, Blitz, Germany) while breathing dry air from a reservoir. Subjects wore a nose clip
and breathed through a mouthpiece connected to the metabolic cart. Heart rate was recorded
continuously using a heart rate monitor (s610i, Polar, Kempele, Finland). Progression of the
workload was estimated [22] and then individually adjusted to reach a _VE 60% MVV by the
4thmin, which was then kept constant for further 4min. Subjects chose their preferred pedaling
frequency at the beginning of the tests which was then held constant throughout the study. The
individual workload profiles for both, ECh and CET were determined in the CON condition
and kept constant for all further testings. The CET protocol started with two submaximal 30-s
stages (80% and 90% of the final ECh-workload), after which participants cycled at 100% of the
final ECh-workload until volitional exhaustion. At baseline, every 2min during both exercise
tests and at exhaustion (CET only) subjects rated their perception of respiratory sensations and
leg exertion. After each rating, 20μl of capillary blood was drawn from an earlobe to analyse
blood lactate concentration (BIOSEN C-line Sports, EKF-diagnostic, Barleben, Germany).
Airway impedance
Airway resistance at 5Hz (R5) and 20Hz (R20) and the difference between the two (R5-R20),
airway reactance at 5Hz (X5) and reactance area from 5Hz to resonance frequency (AX) were
Fig 1. Study outline of 2nd to 6th visit. At baseline and in 5min intervals after control warm-up (CON), SHAM or hyperpnea warm-up (WU)
and after the exercise challenge (ECh), airway impedance, perception of respiratory sensations and lung function (#) were measured until
30min into recovery from ECh and the start of the constant-load cycling test to exhaustion (CET). Warm-up (WU) consisted of normocapnic
hyperpnea at 10% (SHAM), 50% (WU50), variable intensity (8x 30s-80%/45s-30%; WU80/30) or 70% (WU70) maximal voluntary ventilation
with tidal volume set at 50–60% of vital capacity. On 2nd visit, all subjects performed CON followed by ECh and CET. On subsequent visits,
subjects performed either SHAM, WU50, WU80/30 or WU70 in randomized and balanced order, followed by ECh and CET. See text for
details.
doi:10.1371/journal.pone.0167318.g001
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measured according to the current guideline [23] using the MasterScreen Impulse Oscillome-
try System (Jaeger, Hoechberg, Germany). At baseline, at least 3 measurements were per-
formed and the average thereof was taken as the final value. In the breaks, one measurement
per time-point was performed due to time restrictions.
Lung function
Lung function was measured using the metabolic cart. FVC, FEV1, FEV1/FVC, peak expiratory
flow (PEF), forced expiratory flow between 25 and 75% FVC (FEF25−75%) and MVV were mea-
sured according to current guidelines [24]. Predicted values were derived from Quanjer et al.
[25,26].
Respiratory sensations and leg exertion
Perception of breathlessness (the sensation of “not getting enough air”), respiratory exertion
(“work/effort that is required by breathing”) and leg exertion (“work/effort that is required by
cycling exercise”) were measured using a visual analogue scale with “no” as starting point and
“maximal” as end point.
Data analysis
A minimal sample size of nine was derived from published work by Dahlen et al. (2001)
addressing reproducibility and sample size requirements of exercise-induced bronchoconstric-
tion measurements [27]. Effects of pre-exercise hyperpnea and ECh on lung function and air-
way impedance were assessed by comparing values after warm-up and after ECh with values at
baseline. Changes in CON and SHAM conditions did not significantly differ. Since three sub-
jects showed a potential response to the SHAM intervention, effects of the different WU-strat-
egies were compared to CON (for details, please see in chapter Changes after the ECh and S1–
S4 Figs). The degree of bronchoprotection by pre-exercise hyperpnea was calculated by sub-
tracting the maximal decrease in FEV1 after ECh in the respective condition from the maximal
decrease in the CON condition, and expressed as percentage of the CON condition.
Data were tested for normality using the Shapiro-Wilk-test and compared between condi-
tions and time-points using repeated measures ANOVA with Bonferroni-corrections. To fur-
ther assess mechanistic aspects, i.e. whether differences in bronchoprotection seen in this
study would translate into improvements in airway resistance and respiratory sensations or
whether differences in FEV1 seen in this study would be large enough to affect CET-perfor-
mance at all, we compared 1) airway resistance and respiratory sensations in the trial with best
bronchoprotection with the CON trial and 2) performance in the trial with the best (least com-
promised) FEV1, with performance in the CON trial using paired t-tests or, in case of non-nor-
mal distributed data, Wilcoxon signed rank test. Pearson’s correlation or, for non-normal
distributed data, Spearman’s correlation was used to assess the relationship between maximal
changes in FEV1 and airway impedance parameters. SPSS Statistics 21 (IBM Company, New
York, USA) was used for statistical analyses. Values are given as mean ± SD unless otherwise
stated. For all statistical tests p0.05 was considered significant.
Results
Baseline lung function and airway impedance were not significantly different between days
(S1 Table). Maximal changes in FVC, FEV1, PEF, FEF25-75%, R20, X5 and AX after the 10-min
pre-exercise intervention were not different between CON and the hyperpnea warm-up
Pre-Exercise Hyperpnea Attenuates EIB
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conditions except for R5 which was slightly higher after WU80/30 warm-up compared to
CON (S2 Table). In none of the instances, decreases in FEV1 were10% (range: −8.3 to
+7.5%).
Physiological variables during the ECh
Workload, ventilation, gas exchange, heart rate, blood lactate concentrations, perception of
breathlessness, respiratory and leg exertion in the ECh did not significantly differ between
conditions (Table 2). An overall effect of warm-up on heart rate and perception of respiratory
exertion was observed but with no significant differences between conditions.
Changes after the ECh
The maximal decline in FEV1 after ECh did not differ between CON (-13.8%, 95% CI:
-16.1–-11.4%) and SHAM (-11.3%, 95% CI: -16.9–-5.6%, p = 0.215). However, three out of
nine subjects showed a substantial attenuation in the maximal decline in FEV1 after ECh in the
SHAM condition compared to CON (difference in ΔFEV1 between SHAM and CON: 9.0
±0.8% [n = 3] versus -0.7±3.4% [n = 6]; S1 Fig). This difference was similar to differences
observed after WU50 (6.5±4.0% [n = 3]), WU80/30 (9.3±1.9% [n = 3]) and WU70 (10.2±2.8%
Table 2. Physiological variables during the 8-min exercise challenges.
CON WU50 WU80/30 WU70 p-value
Workload (W) m±SD 199.7±46.8 199.6±45.7 200.9±46.7 199.9±46.3 0.322
95%-CI 163.7-235.6 164.5-234.7 165.0-236.9 164.4-235.5
_VE (Lmin−1) m±SD 80.0±14.5 81.6±17.1 82.8±16.9 82.2±15.3 0.326
95%-CI 68.9-91.2 68.4-94.8 69.8-95.8 70.4-93.9
VT (L) m±SD 2.5±0.6 2.5±0.5 2.5±0.6 2.4±0.5 0.328
95%-CI 2.1-3.0 2.0-2.9 2.1-2.9 2.0-2.8
fR (min−1) m±SD 32.2±7.7 33.3±6.7 34.0±8.7 34.3±5.9 0.351
95%-CI 26.3-38.0 28.2-38.4 27.3-40.7 29.8-38.8
_VO2 (Lmin−1) m±SD 2.6±0.6 2.6±0.6 2.6±0.6 2.6±0.5 0.360
95%-CI 2.2-3.1 2.1-3.0 2.1-3.1 2.2-3.0
_VCO2 (Lmin−1) m±SD 2.8±0.6 2.7±0.6 2.8±0.6 2.8±0.6 0.146
95%-CI 2.4-3.3 2.3-3.2 2.4-3.3 2.3-3.2
Heart rate (min−1) m±SD 161.2±5.3 158.0±7.5 157.5±7.1 156.8±7.8 0.009
95%-CI 157.2-165.2 152.2-163.8 152.1-163.0 150.8-162.8
Lactate (mmolL−1) m±SD 6.48±1.22 6.01±1.32 6.14±0.74 6.13±1.15 0.335
95%-CI 5.54-7.42 4.99-7.02 5.57-6.71 5.25-7.02
Breathlessness (points) m±SD 1.1±0.9 0.9±0.6 0.9±0.8 0.9±0.6 0.652
95%-CI 0.5-1.8 0.4-1.4 0.3-1.5 0.5-1.4
Respiratory exertion (points) m±SD 2.7±1.0 1.9±1.1 1.8±1.0 2.2±0.7 0.017
95%-CI 1.9-3.4 1.0-2.8 1.1-2.6 1.7-2.8
Leg exertion (points) m±SD 3.3±1.1 3.3±1.4 3.2±1.1 3.5±1.0 0.877
95%-CI 2.4-4.1 2.2-4.4 2.4-4.1 2.7-4.3
Data (n = 9) are presented as mean ± standard deviation (m±SD) and 95% confidence intervals (95%-CI). No significant post-hoc differences were present
for any variables between conditions. CON: control warm-up; WU50: hyperpnea at 50% maximal voluntary ventilation (MVV); WU80/30: hyperpnea at 80
and 30% MVV; WU70: hyperpnea at 70% MVV; _VE, minute ventilation; VT, tidal volume; fR, respiratory frequency; _VO2, oxygen consumption; _VCO2, carbon
dioxide production.
doi:10.1371/journal.pone.0167318.t002
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[n = 3]). Possibly, for these three subjects, SHAM maneuvers with tidal volumes similar to
WU were sufficient to already show warm-up effects at 10% MVV. To avoid misinterpretation
in subsequent analyses, data for SHAM was omitted and WU-conditions were compared to
CON. An alternative analysis taking into account the observed heterogeneity given in the
SHAM trial is presented in S3 and S4 Figs.
Maximal changes in FEV1, FVC, PEF and FEF25-75% after ECh are given in Fig 2. A main
effect of condition was detected for FEV1 (p = 0.007), FVC (p = 0.015) and FEF25-75%
(p = 0.025), with significantly attenuated maximal decreases in FEV1 after WU70 and
FEF25-75% after WU50 and WU70 compared to CON. The average decrease in FEV1 over
the entire recovery period was -8.4% (95% CI: -11.1–-5.7%) following CON, -4.8% (95% CI:
-7.9–-1.8%) following WU50, -4.7% (95% CI: -10.0–0.6%) following WU80/30 and -3.6%
(95% CI: -7.4–0.3%) following WU70. There was a main effect of condition (p = 0.035) with
no significant post-hoc differences.
Maximal changes in R5, R20, X5 and AX after ECh are depicted in Fig 3. There was no dif-
ference between conditions in any of the parameters. Maximal changes in FEV1 were only
weakly correlated with variables of airway impedance (R5, r = -0.60, p<0.001; R20, rho =
-0.45, p = 0.006; X5, rho = -0.47, p = 0.004; AX, rho = -0.52, p = 0.001).
The maximal increase in respiratory exertion after ECh was significantly smaller in WU50
(1.6 points, 95% CI: 0.6–2.5, p = 0.009), WU80/30 (1.6 points, 95% CI: 0.8–2.4, p = 0.009) and
WU70 (2.1 points, 95% CI: 1.3–3.0, p = 0.048) compared to CON (3.7 points, 95% CI: 1.9–5.5).
The maximal increase in perception of breathlessness did not differ after ECh in WU50 (1.4
points, 95% CI: 0.4–2.4, p = 0.237), WU80/30 (1.9 points, 95% CI: 0.5–3.3, p = 0.258) and
WU70 (1.5 points, 95% CI: 0.2–2.8, p = 0.405) compared to CON (2.7 points, 95% CI: 0.7–4.6).
The average degree of bronchoprotection was 32% (WU50, 95% CI: 2–62%), 43%
(WU80/30, 95% CI: 7–79%) and 49% (WU70, 95% CI: 22–76%), and did not differ between
warm-up conditions (p = 0.451).
In the warm-up trial with the highest degree of bronchoprotection (69%, 95% CI: 50–87%),
the 10-min warm-up significantly increased R5 acutely after warm-up (20%, 95% CI: 10–30%)
compared to CON (4%, 95% CI: 0–8%, p = 0.020). Furthermore, maximal increases in R5
(p = 0.041), breathlessness (p = 0.043) and respiratory exertion (p = 0.005) were significantly
attenuated after the ECh compared to CON. These changes did not result from altered ventila-
tion during the preceding ECh (p = 0.382).
Effects on time to exhaustion and physiological variables during CET
Immediately before CET, FEV1 was still significantly reduced in CON (−8.0%, 95% CI:
-11.3–-4.7%, p = 0.004) while it did not anymore differ from baseline in the WU50 (-3.8%,
95% CI: -7.9–0.3%, p = 0.300), WU80/30 (-3.1%, 95%CI:-8.7–2.4%, p>1.000) and WU70
(-4.9%, -8.6–-1.2% p = 0.120) condition. Times to exhaustion (p = 0.582), ventilation, gas
exchange, subjective measures (Figs 4 and 5), heart rate and blood lactate concentration (both
p>0.562) did not differ between conditions. Also, when comparing values of the WU-trial
with the individually best FEV1 immediately before the start of the CET (3.8 L, 95% CI: 3.2–
4.5 L) with CON (3.6 L, 95% CI: 3.1–4.0 L; p = 0.025), ventilation, gas exchange, heart rate,
subjective ratings and time to exhaustion were not different from CON (all p>0.069).
Discussion
Results of the present study suggest that, in mild asthmatics with EIB, pre-exercise hyperpnea
of different intensity, using warm and humid air, does not induce bronchoconstriction, may
attenuate the decrease in lung function and does not negatively affect performance.
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Effects of pre-exercise hyperpnea on airway function after ECh
Warm-up with physical exercise, inducing EIB by itself, was shown to improve EIB in a subse-
quent exercise with bronchoprotection ranging from ~6 to 70% [6–11], a level achieved in the
present study with isolated hyperpnea as well. The present study thus provides evidence that
even non-EIB-inducing and respiratory-only warm-up may induce bronchoprotection.
Fig 2. Individual (dots) and mean (line) maximal changes (Δ) from baseline after the exercise challenge in A) forced
expiratory volume in 1s (FEV1), B) forced vital capacity (FVC), C) peak expiratory flow (PEF) and D) forced expiratory flow
between 25 and 75% FVC (FEF25-75%) after the different types of 10-min pre-exercise interventions. CON, control warm-up;
WU50, hyperpnea at 50% maximal voluntary ventilation (MVV); WU80/30, hyperpnea at 80 and 30% MVV; WU70, hyperpnea at 70%
MVV. Dotted line at −10% (FEV1) represents a clinically relevant change from baseline. *, ** significantly different from CON (p0.05
and p<0.01, respectively).
doi:10.1371/journal.pone.0167318.g002
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Positive effects of warm-up on FEV1, FVC and FEF25-75%were larger and more consistent
than those on PEF while previous studies also reported attenuated declines in PEF after exer-
cise warm-up interventions [6,9]. Since PEF is known to be primarily effort-dependent [28],
also effort-independent parameters of airway impedance were measured in the present study.
However, improvements in impedance with warm-up were minimal and maximal changes
Fig 3. Individual (dots) and mean (line) maximal changes (Δ) from baseline after the exercise challenge in A) airway
resistance measured at an impulse frequency of 5Hz (R5), B) airway resistance measured at 20Hz (R20), C) airway reactance
measured at 5Hz (X5) and D) reactance area from 5Hz to resonance frequency (AX) after the different types of 10-min pre-
exercise interventions. CON, no warm-up; WU50, hyperpnea at 50% maximal voluntary ventilation (MVV); WU80/30, hyperpnea at
80 and 30% MVV; WU70, hyperpnea at 70% MVV. Dotted lines at +50% (R5) and +90% (X5) represent clinically relevant changes
from baseline.
doi:10.1371/journal.pone.0167318.g003
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correlated only weakly with FEV1. Although we need to consider that—due to time restric-
tions—breaks between spirometry and impulse oscillometry were shorter than recommended
[23] and only one single oscillometry measurement was performed per time-point in the
breaks. This might have resulted in higher airway impedance or less attenuation compared to
lege-artis measurements since deep inspirations (as performed during spirometry) are known
to increase airway resistance in asthmatics per se [29]. However, when selecting the best trial
in terms of the bronchoprotection index, the maximal increase in airway resistance after ECh
was significantly smaller than in CON. Also, those subjects with pathological increases in R5
and X5 following CON showed improvements in the warm-up trials, reaching levels below
clinical thresholds in most cases. Thus with more severe airway dysfunction, improvements in
impedance can be expected to be more pronounced and consistent.
Fig 4. Ventilation, tidal volume, respiratory frequency and oxygen (O2) consumption during the endurance test in each condition.
Values are mean ± SE. L85%, 1min of incremental submaximal stages consisting of 30s at 80% and 30s at 90% of the target workload; CON, no
warm-up; WU50, hyperpnea at 50% maximal voluntary ventilation (MVV); WU80/30, hyperpnea at 80 and 30% MVV; WU70, hyperpnea at
70% MVV.
doi:10.1371/journal.pone.0167318.g004
Pre-Exercise Hyperpnea Attenuates EIB
PLOS ONE | DOI:10.1371/journal.pone.0167318 November 29, 2016 10 / 16
Asthma symptoms, e.g. cough, wheeze, chest tightness, shortness of breath, or excessive
mucous production occur frequently in asthmatics in the context of exercise [30,31]. Whether
warm-up exercises aiming at attenuating EIB has also effects on asthma symptoms is unclear
but might be expected. We are aware of only one study reporting significantly less wheezing
after exercise with warm-up compared to the exercise without [7]. Data from the present study
suggest only minimal effects of warm-up on perception of breathlessness and respiratory exer-
tion during the ECh while perception of respiratory exertion was significantly reduced after
the ECh in all WU-trials. Additionally, in the subgroup analysis considering only the trial with
the greatest degree of bronchoprotection, both a significantly reduced perception of breath-
lessness and respiratory exertion were observed after ECh. Given the high prevalence of
Fig 5. Breathlessness, respiratory exertion and leg exertion during the endurance test in each condition. Values are mean ± SE. 0,
before start of exercise; L85%, 1min of incremental submaximal stages consisting of 30s at 80% and 30s at 90% of the target workload; CON,
no warm-up; WU50, hyperpnea at 50% maximal voluntary ventilation (MVV); WU80/30, hyperpnea at 80 and 30% MVV; WU70, hyperpnea at
70% MVV.
doi:10.1371/journal.pone.0167318.g005
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exercise-induced respiratory symptoms and their potential association with avoidance of phys-
ical activity [30], factors reducing these symptoms certainly deserve further investigations.
In the present study, moderate-, alternating (high/low)- and high-intensity warm-up strate-
gies were chosen based on previous findings with hyperpnea [14,32] and with physical exercise
warm-up trials [8,10]. According to a recent meta-analysis, most pronounced effects were
expected to occur after interval and variable intensity respiratory warm-up since both continu-
ous low- and high-intensity warm-up did not provide significant improvements [13]. How-
ever, this meta-analysis was based on studies using different protocols in different groups of
subjects. Only two studies varied warm-up intensity without changing the duration of the
warm-up or the break prior to the next exercise [8,11] and both found no significant effects
after interval exercise but attenuated EIB after continuous moderate or low-intensity running
—a finding which was not seen in the meta-analysis. In the present study, however, where tim-
ing was kept similar, only the continuous respiratory exercise at high intensity offered signifi-
cant bronchoprotection while interval as well as continuous respiratory exercise at moderate
intensity showed improvements only by tendency. Thus, the modality and protocol with the
best bronchoprotective effect still remain to be established.
Regarding potentially different effects of different warm-up modalities, bronchoprotective
prostaglandins (e.g. PGE2) need to be considered. In fact, pre-treatment with COX-inhibitors
(e.g. indomethacine) significantly abolished refractoriness to repeated physical exercise, inde-
pendent of intensity or the condition of inspired air [17,33]. No such inhibitor-induced sup-
pression was observed in a study with repeated hyperpnea challenges [34], suggesting that
exercise per se and not the level of ventilation might trigger release of protective PGs. This is,
however, challenged by an in-vitro study where cyclic stretch of airway epithelial cells
increased PGE2 release in a frequency-dependent manner [35] and also by a recent study that
showed increased PGE2 concentrations after hyperpnea and significant refractoriness after a
subsequent second hyperpnea [36]. It thus seems conceivable that, in the present study, hyper-
pnea but not NWU stretched the airways enough to release PGE2, reduce EIB severity and
improve lung function recovery, possibly via blocking leukotriene-receptors on airway endo-
thelial cells, thereby inhibiting their bronchoconstrictive effects [37]. Reduced EIB severity and
improved lung function recovery were previously shown after selectively antagonizing hista-
mine and leukotriene [38]. The fact that airway resistance was increased after hyperpnea in
warm-up trials with the highest degree of bronchoprotection, also points towards this mecha-
nism. This finding confirms previous results where an interplay of bronchoconstrictive and
bronchoprotective mediators was suggested to promote refractoriness [39].
Effects of pre-exercise hyperpnea on exercise performance
In the present study, we also aimed to assess whether intense pre-exercise hyperpnea would
negatively affect exercise performance compared to exercise without prior hyperpnea. With
the present design we did not observe a negative effect of the respiratory work performed dur-
ing warm-up on time to exhaustion. However, we need to consider one caveat: Ideally the
CET would have needed to follow hyperpnea directly (without the ECh in between), which
would have meant that subjects needed to perform another 5 tests on independent days. We
therefore opted for the present compromise. This might have influenced the outcome in sev-
eral ways: i) exercise-induced respiratory muscle fatigue could have developed in the ECh
since ventilation in the ECh (~58% MVV) was similar to the level that induced respiratory
muscle fatigue in a previous study (~54% MVV; [40]) which would have compromised perfor-
mance; ii) potential hyperpnea-induced respiratory muscle fatigue might have recovered dur-
ing the ECh (as previously observed–[41]) or in the 30-min break between cycling tests which
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would have masked a fatigue-induced impairment in CET performance; and iii) ECh itself
could have induced a refractory period resulting in decreased airway obstruction such that
performance after CON was better than it would have been without the ECh. However, also
larger degrees of bronchoconstriction prior to a CET would likely not affect performance as
previously shown in a similar setting (-27±15%; [42]).
Conclusion
The present data suggest that intense pre-exercise hyperpnea with partial rebreathing that does
not, by itself, induce EIB, significantly attenuates bronchoconstriction and improves lung
function recovery after an exercise challenge while performance is not affected by the intense
pre-exercise hyperpnea.
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